SecBot SecBot
144 ·Filed Nov 5, 2026

ONC

BeOne Medicines Ltd.
NEUTRAL
Impact 2/10
Horizondays Processed11d 6h ago SEC0001950047-26-010750
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and executed under a pre-arranged 10b5-1 plan, reducing the likelihood of opportunistic insider selling. Monitor for any acceleration of insider sales or changes in the 10b5-1 plan.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$406.96
T+0 close · Nov 5, 2026 · via day close
Latest settled
+2.35%
T+5 · $416.54
Vs SPY
−0.24%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $406.96entry
  2. T+1 · 8d ago +2.55%α +0.18% · $417.33
  3. T+5 · 4d ago +2.35%α −0.24% · $416.54
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Chan Lee, an officer of BeOne Medicines Ltd., filed a Form 144 notice of intent to sell 1,115 ADSs with an approximate market value of $421,224.70. The sale is scheduled for November 5, 2026, and is part of a pre-arranged 10b5-1 trading plan established on July 29, 2022. The filing also references a prior sale of 2,666 ADSs on August 11, 2026, for $959,760.

Key Facts

  • Chan Lee, an officer, filed Form 144 to sell 1,115 ADSs.
  • Estimated market value of the proposed sale is $421,224.70.
  • Sale is scheduled for November 5, 2026.
  • The sale is part of a 10b5-1 trading plan established on July 29, 2022.
  • A prior sale of 2,666 ADSs on August 11, 2026, for $959,760 is also referenced.

Financial Impact

Proposed sale of 1,115 ADSs valued at approximately $421,225, representing a negligible fraction of the $40.4B market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • The filing references a prior larger sale (2,666 ADSs) in August 2026, which could indicate a pattern of insider monetization.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010750
Document: 0001950047-26-010750-index.html0001950047-26-010750
Document: 0001950047-26-010750.txt0001950047-26-010750

Track record

27 reports on ONC

Performance horizon

3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
  2. Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
  3. Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
  4. Nov 5, 202611d ago 144 Neutral 2/10 Viewing Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
  5. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
  6. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
  7. Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
  8. Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
  9. Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
  10. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
Showing 10 of 27

US Market Status

Market Closed · Opens Wed (10h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026